OpenAI 2026 hackathon

CareProof

Evidence-first care reporting for teams that must be trusted.

Solo project by yoshimi musubi · 0 likes · 0 comments

Archive position — measured, not model output

0 likes on Devpost

2,264 of the 7,856 archived projects have more likes, and 5,592 share exactly 0 — so this project's #3,144 place in the like-ranked listing is a tie-break inside that group, not a ranking.

Projects (log scale)

1
10
100
1k
10k
05,592
11,758
2285
3–4132
5–975
10+14

Likes on Devpost. ▲ marks this project's group.

Show the figures
LikesProjectsShare of archive
05,59271.2%
11,75822.4%
22853.6%
3–41321.7%
5–9751.0%
10+140.2%
Devpost like counts for all 7,856 archived projects, captured when this archive was built.

Executive Summary

What the company appears to be

CareProof is a self-reported prototype tool designed to help care organizations generate privacy-safe reports from raw notes or records. The author states it uses OpenAI tools (Codex, GPT-5.6) and is built with TypeScript, React, and Next.js. It runs locally in the browser and aims to support teams that must be trusted by ensuring evidence-based reporting.

What changed

The project was submitted as a hackathon entry for the OpenAI 2026 hackathon. There is no indication of prior development or commercial activity beyond this prototype.

Single most important open question

Is there any evidence of traction, revenue, customer adoption, or real-world validation from care managers or privacy officers?

Note: This analysis is based entirely on the self-reported project description provided by the author. No external verification or historical data exists for this project.

Back to contents

What The Product Actually Is

The description states that CareProof converts pasted notes or CSV/TXT records into a privacy-safe, evidence-linked report. It removes personal identifiers such as phone numbers and participant details; flags unsupported or overly confident conclusions; and gives each statement in the report a source reference. Users can compare original observations with sanitized versions, switch between English and Japanese, copy reports, export sanitized CSVs, or print to PDF.

All processing runs locally in the browser. The tool is described as a working bilingual prototype with an end-to-end review flow, allowing users to load fictional care notes, see a report immediately, trace every statement back to its source line, review privacy redactions and risky language, and export a safe dataset.

Inference: The product appears to be a proof-of-concept for transforming unstructured care data into structured, auditable reports while preserving privacy. It is not yet a commercial product but rather an early-stage prototype.

Back to contents

Positioning & Claim Evolution

The author states that CareProof was inspired by the challenge of turning frontline care notes into client-facing reports quickly and safely. The tool aims to avoid common pitfalls like leaking personal identifiers, making unsupported claims, or losing connection to source data.

The positioning is framed around trustworthiness, evidence-based reporting, and privacy safety. It explicitly positions itself as decision support rather than medical advice. The author also emphasizes that the output is deterministic and local-first so judges can inspect transformations without sending sensitive data externally.

Claim: CareProof supports teams that must be trusted by ensuring privacy, provenance, and professional judgment are preserved in reporting workflows.

Inference: This is a self-positioning statement. No external validation or market positioning data is available.

Back to contents

Target Customer & ICP

The description states that the tool is aimed at care organizations that create frontline records daily but struggle with turning those notes into reports for clients, partners, or supervisors. These users are described as needing to be trusted — implying a high level of responsibility and regulatory compliance.

Claim: Care organizations that must be trusted.

Inference: The ICP is inferred from the stated use case and target audience. No explicit segmentation or customer personas are provided.

Back to contents

Business Model & Pricing Evidence

There is no evidence in the description of a business model, pricing strategy, monetization approach, or any indication of how the tool would be sold or used commercially.

Not evidenced: No information on revenue streams, pricing tiers, licensing models, or commercial plans.

Back to contents

Technical & Delivery Signals

The product was built with OpenAI Codex and GPT-5.6 as primary development environments. It uses TypeScript, React, Next.js, Vinext, and Cloudflare-compatible deployment tooling. The analysis is described as deterministic and local-first to ensure transparency and auditability.

Claim: Built using OpenAI tools (Codex, GPT-5.6), TypeScript, React, Next.js.

Inference: The technical stack reflects a modern frontend architecture with AI-assisted development. However, no production deployment or scalability data is provided.

Back to contents

Traction & Maturity Signals

The project is described as a working prototype submitted to the OpenAI 2026 hackathon. It includes an end-to-end review flow and has been validated internally through fictional data. There is no evidence of real-world usage, customer feedback, or adoption beyond the hackathon submission.

Not evidenced: No traction, user base, or adoption metrics are reported.

Back to contents

Competitive Context

No mention of competitors or competitive landscape is present in the description. The author does not reference similar tools or platforms that might address care reporting or privacy-preserving data transformation.

Not evidenced: No competitive analysis or positioning against existing solutions.

Back to contents

Key Risks & Red Flags

  • Prototype-only status: The tool is a hackathon prototype with no commercial rollout.
  • No real-world validation: No evidence of testing with actual care managers or privacy officers.
  • Unverified claims: The author makes strong claims about trustworthiness and safety without external corroboration.
  • Local-first design may limit scalability: While good for auditability, running everything locally could be a barrier to broader adoption.
  • AI dependency: Heavy reliance on OpenAI tools raises questions about future availability or cost.

Inference: The lack of real-world validation and commercial readiness poses significant risk for any investment or partnership interest.

Back to contents

Diligence Questions To Ask The Founders

  1. What specific care workflows does CareProof aim to support, and how do those align with current regulatory requirements?
  2. Has the tool been tested with actual care managers or privacy officers? If so, what feedback was received?
  3. How is the tool intended to be monetized or scaled beyond a prototype?
  4. Are there any plans for integrating with existing EHR or care management systems?
  5. What are the limitations of the current deterministic approach, and how would they be addressed in a production environment?
  6. How does CareProof handle edge cases where evidence is ambiguous or incomplete?

Back to contents

Investment/Partnership Verdict

At this stage, there is no evidence of commercial traction, revenue, customer adoption, or validated market demand. The project is described as a hackathon prototype with limited functionality and no clear path to market.

Verdict: Not ready for investment or partnership consideration. A significant amount of development, validation, and product-market fit testing would be required before any meaningful due diligence could proceed.

Back to contents

Source

Submitted to the OpenAI 2026 hackathon on Devpost. Project home on DevPost.

The analysis above was generated by a language model from the project's own one-line description. It is not independent research and contains no verified traction, revenue or customer data.